News for Mesoblast Limited (LWBA.F)

Management Team Mesoblast has a highly experienced management team made up of individuals who have held senior positions in international pharmaceutical and... | February 13, 2021

MESOBLAST PHASE 3 TRIAL SHOWS THAT A SINGLE INJECTION OF REXLEMESTROCEL-L + HYALURONIC ACID CARRIER RESULTS IN AT LEAST TWO YEARS OF PAIN REDUCTION WITH OPIOID... | February 10, 2021

MESOBLAST CORPORATE UPDATE Melbourne, Australia; February 11, and New York, USA; February 10, 2021: Mesoblast Limited , global leader in allogeneic cellular... | February 10, 2021

NEW YORK, Feb. 10, 2021 -- Mesoblast Limited , global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast today to provide a corporate update. The webcast... | February 10, 2021

NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory ...

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory ...

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflamm...

What's moving these stocks in pre-market hours today?.

Today's Daily Dose brings you news about Lilly's Alzheimer's disease trial data, BeiGene's collaboration agreement with Novartis, Mesoblast's encouraging results from phase III trial of Rexlemestrocel-L in patients with chronic heart failure, and the resignation of Editas' Chief Scientific Officer.

Toward the end of trading Monday, the Dow traded down 0.33% to 30,996.80 while the NASDAQ fell 1% to 13,070.16. The S&P also fell, dropping 0....

Toward the end of trading Monday, the Dow traded down 0.33% to 30,996.80 while the NASDAQ fell 1% to 13,070.16. The S&P also fell, dropping 0.59% to ...

Midway through trading Monday, the Dow traded down 0.23% to 31,027.86 while the NASDAQ fell 0.77% to 13,100.74. The S&P also fell, dropping 0.36% to ...